Dihydrostreptomycin

DB11512ApprovedVet approvedWithdrawnSmall molecule

Dihydrostreptomycin is an aminoglycoside antibiotic. In humans, the use of dihydrostreptomycin has been associated with ototoxicity. The FDA withdrew its approval for the use of all drug products containing dihydrostreptomycin...

Chemical structure of Dihydrostreptomycin
Formula / weight
C21H41N7O12 · 583.596 g/mol (avg)
Also known as
DHMS

Resolves to

Compound
UNIIP2I6R8W6UACAS128-46-1ChEMBLCHEMBL1950576ChEBI38291KEGGD07840
Clinical / RWD
RxNorm1549540ATCS01AA15
Structure
InChIKeyASXBYYWOLISCLQ-HZYVHMACSA-NSMILESCN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]2NC(N)=N)O[C@@H](C)[C@]1(O)CO
Targets
Q8TDI7TMC2Q8TDI8TMC1

What you can answer from here — as of September 19, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
877Drug interactionsStructured to mechanism, not free text
Sign in
1ATC codeIncluding every combination product, plus 9 drug categories
Sign in
15+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Dihydrostreptomycin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In